Bridgeway Capital Management’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-120,900
| Closed | -$86.7K | – | 1273 |
|
|
2025
Q1 | $86.7K | Sell |
120,900
-11,700
| -9% | -$8.4K | ﹤0.01% | 1064 |
|
|
2024
Q4 | $147K | Sell |
132,600
-3,300
| -2% | -$3.66K | ﹤0.01% | 1057 |
|
|
2024
Q3 | $95.1K | Sell |
135,900
-30,000
| -18% | -$21K | ﹤0.01% | 1165 |
|
|
2024
Q2 | $166K | Buy |
165,900
+33,200
| +25% | +$33.2K | ﹤0.01% | 1089 |
|
|
2024
Q1 | $314K | Sell |
132,700
-30,000
| -18% | -$71.1K | 0.01% | 1030 |
|
|
2023
Q4 | $366K | Hold |
162,700
| – | – | 0.01% | 1017 |
|
|
2023
Q3 | $345K | Buy |
162,700
+62,500
| +62% | +$133K | 0.01% | 979 |
|
|
2023
Q2 | $310K | Hold |
100,200
| – | – | 0.01% | 1038 |
|
|
2023
Q1 | $539K | Hold |
100,200
| – | – | 0.01% | 867 |
|
|
2022
Q4 | $666K | Buy |
100,200
+20,800
| +26% | +$138K | 0.02% | 827 |
|
|
2022
Q3 | $316K | Buy |
79,400
+10,000
| +14% | +$39.8K | 0.01% | 1019 |
|
|
2022
Q2 | $345K | Buy |
+69,400
| New | +$345K | 0.01% | 964 |
|